The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2017
Filed:
Nov. 17, 2015
Applicant:
Socpra Sciences Sante ET Humaines S.e.c., Sherbrooke, CA;
Inventors:
Martin Richter, Sherbrooke, CA;
Richard Leduc, Sherbrooke, CA;
Eloic Colombo, Sherbrooke, CA;
Eric Marsault, Sherbrooke, CA;
Assignee:
SOCPRA SCIENCES SANTE ET HUMAINES S.E.C., Quebec, CA;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/425 (2006.01); A61K 31/42 (2006.01); A61K 31/41 (2006.01); C12N 15/113 (2010.01); A61K 45/06 (2006.01); A61K 31/713 (2006.01); C12N 9/64 (2006.01); A61K 31/427 (2006.01); C07K 16/40 (2006.01); A61K 38/07 (2006.01); C07K 5/11 (2006.01); C07K 5/062 (2006.01); C07K 5/093 (2006.01); C07K 5/09 (2006.01); C07K 5/072 (2006.01); A61K 31/428 (2006.01); A61K 38/06 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1131 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/713 (2013.01); A61K 38/06 (2013.01); A61K 38/07 (2013.01); A61K 45/06 (2013.01); C07K 5/06026 (2013.01); C07K 5/06095 (2013.01); C07K 5/06104 (2013.01); C07K 5/0817 (2013.01); C07K 5/0819 (2013.01); C07K 5/1019 (2013.01); C07K 16/40 (2013.01); C12N 9/6424 (2013.01); A61K 9/0075 (2013.01); A61K 9/0078 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C12N 2310/14 (2013.01);
Abstract
The present invention provides matriptase inhibitors and compositions for treating and preventing orthomyxovirus infections such as flu infections. The present invention also provides novel compounds, compositions, methods of use, uses and kits thereof for inhibiting matriptase. Such compounds are useful for treating and preventing orthomyxovirus infections, such as flu infections, and for inhibiting tumor growth, progression and/or metastasis.